Veronia Abadeer, OD
Optometrist · Port Richey, FLNPI 1609509165
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (32.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 65.9% of it on its own, with 10 other manufacturers making up the rest. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $187.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$8K
- Alcon$2K
- Bausch & Lomb Americas Inc.$1K
- Johnson & Johnson Vision Care, Inc.$312
- Dompe US, Inc.$212
- Optos, Inc.$167
- plus $488 from 5 others
What the payments were for
- Consulting fees$2,18818%
- Speaking & faculty fees$2,96524%
- Travel & lodging$4,01333%
- Food & beverage$2,86924%
- Entertainment$1671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 16 | $8,043 |
| Alcon | 14 | $1,624 |
| Bausch & Lomb Americas Inc. | 17 | $1,356 |
| Johnson & Johnson Vision Care, Inc. | 6 | $312 |
| Dompe US, Inc. | 4 | $212 |
| Optos, Inc. | 1 | $167 |
| Biotissue Holdings Inc. | 3 | $148 |
| Amgen | 1 | $125 |
| Topcon Healthcare, Inc. | 1 | $103 |
| Oyster Point Pharma, Inc. | 1 | $84 |
| AbbVie | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SynergEyes contact lens$4,000
- Onefit Contact Lens$3,573
- OCT OPHTHALMOSCOPE$335
- PANORAMIC OPHTHALMOSCOPE$335
- INFUSE$239
- NFC-700$167
- Acuvue$149
- TEPEZZA$125
- INFUSE MULTIFOCAL$125
- Oxervate$121
- Prokera$111
- VYZULTA$103
How this compares
$12,202 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $170 |
| Latanoprost | 17 | $78 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Port Richey
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
- Robert DavisPembroke Pines$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.